The U.S. decision to allow Ukraine to fire American weapons deeper into Russia has not increased the risk of a nuclear attack, which is unlikely, despite Russian President ...
The way the dinosaurs relinquished their long dominance is well known. An asteroid struck Earth 66 million years ...
China's top legislator Zhao Leji expressed China's commitment to advancing China-Spain relations and fostering a relationship that supports the steady, long-term growth of China-Europe ties, during ...
Lebanon's Hezbollah movement fired heavy rocket barrages at Israel on Sunday, with Israeli media reporting that a building had been hit near Tel Aviv, after a powerful Israeli ...
Scientists have taken a close-up picture of a star apparently in its death throes, surrounded by gas and dust as ...
Ukraine fired a volley of British Storm Shadow cruise missiles into Russia on Wednesday, the latest new Western weapo ...
A unified voice calling for bolder actions to decarbonize the maritime transport and ensure a green transition has been heard in the World Maritime Merchants Forum 2024, which officially concluded on ...
President Joe Biden's administration has allowed Ukraine to use U.S.-made weapons to strike deep into Russia, two U.S. officials and a source familiar with the decision said on ...
Ice cream brand Ben & Jerry's said in a lawsuit filed Wednesday that parent company Unilever has silenced its attempts to express support for Palestinian refugees and threatened to ...
阿里巴巴 (09988)公布, 完成發行本金總額為26億5000萬美元, 以美元計價的優先無擔保票據 , 分別在2030年、 2035年及2054年到期, 利率為4.875厘、 5.25厘及5.625厘. 此外, 完成發行本金總額為170億元人民幣, 以人民幣計價的優先無擔保票據, 分別於2028年、2029年、2034年, 及2044年到期, 利率為2.65厘、2.8厘、 3.1厘, 及3.5厘 ...
內地發布關於數字貿易改革創新發展的意見提出, 加強關鍵核心技術創新, 加快發展通信、物聯網、雲計算、 人工智能、區塊鏈、衛星導航等領域對外貿易; 推動電信、互聯網、文化等領域有序擴大開放, 鼓勵外商擴大數字領域投資. 新華社發布的意見全文顯示, 要積極推進加入數字經濟夥伴關係協定(DEPA), 和全面與進步跨太平洋夥伴關係協定(CPTPP)進程. 到2035年, 可數字化交付的服務 ...
和黃醫藥(00013)宣布, 經過與國家醫保局的醫保續約, 沃瑞沙®(ORPATHYS®, 賽沃替尼/savolitinib)將繼續獲納入自2025年1月1日起生效的新版《國家基本醫療保險、工傷保險和生育保險藥品目錄》, 並維持與現行兩年期協議相同的條款. 沃瑞沙®是一種強效、 高選擇性的口服MET 酪氨酸激酶抑制劑(TKI). 其於2021年6月在中國獲附條件批准, 用於治療特定 ...